Strategies That Make a Difference

Rx-to-OTC Switch

NCI Consulting has been a leader in Rx-to-OTC switch evaluation, strategy development and implementation for over 25 years. We have worked on more than 40 switches and have evaluated several hundred other switch opportunities, US and global.

We have experience in nearly every category that has switched and many other categories with switch potential, including:

  • H2 blockers
  • Proton pump inhibitors
  • Vaginal yeast infection treatments
  • Athlete's foot treatments
  • Expectorants
  • Antihistamines
  • Smoking cessation
  • Analgesics
  • Emergency contraception
  • Anti-infectives
  • Acne
  • Oral contraception
  • Urinary incontinence
  • Antidyslipidemics
  • Erectile dysfunction treatments
  • Psoriasis and itch treatments
  • Antihypertensive
  • Migraine treatments
  • Antidiabetics
  • Benign prostatic hyperplasia
  • Antivirals
  • Suncare and photo-aging
  • Nasal steroids